[1]
|
王明阳, 王光磊, 陈新亮, 张燚, 龙淼. MicroRNA的生物学功能及其与肿瘤诊断和治疗的研究进展[J]. 动物医学进展, 2018, 39(1): 95-98.
|
[2]
|
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. https://doi.org/10.1016/0092-8674(93)90529-Y
|
[3]
|
Khan, S., Ayub, H., Khan, T. and Wahid, F. (2019) Mi-croRNA Biogenesis, Gene Silencing Mechanisms and Role in Breast, Ovarian and Prostate Cancer. Biochimie, 167, 12-24. https://doi.org/10.1016/j.biochi.2019.09.001
|
[4]
|
Pattarayan, D., Thimmulappa, R.K., Ravikumar, V. and Rajasekaran, S. (2018) Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases. Clinical Reviews in Al-lergy & Immunology, 54, 480-492.
https://doi.org/10.1007/s12016-016-8589-9
|
[5]
|
李欣, 罗小玲. miRNA调控肿瘤微环境的研究进展[J]. 现代免疫学, 2019, 39(3): 245-248.
|
[6]
|
Krol, J., Loedige, I. and Filipowicz, W. (2010) The Widespread Regulation of mi-croRNA Biogenesis, Function and Decay. Nature Reviews Genetics, 11, 597-610. https://doi.org/10.1038/nrg2843
|
[7]
|
马威, 陈爱娣, 古日珍, 朱利容, 郭君. 不同检查联合在乳腺癌中的诊断价值分析[J]. 影像研究与医学应用, 2020, 4(21): 203-204.
|
[8]
|
Liu, X., Li, Y., Li, Z. and Hou, T. (2021) MiR-155 Promotes Proliferation and Epithelial-Mesenchymal Transition of MCF-7 Cells. Experimental and Therapeutic Medicine, 21, Article No. 218. https://doi.org/10.3892/etm.2021.9650
|
[9]
|
Fan, T., Mao, Y., Sun, Q., Liu, F., Lin, J.-S., Liu, Y., Cui, J. and Jiang, Y. (2018) Branched Rolling Circle Amplification Method for Measuring Serum Circulating mi-croRNA Levels for Early Breast Cancer Detection. Cancer Science, 109, 2897-2906. https://doi.org/10.1111/cas.13725
|
[10]
|
Song, X., Liu, Z. and Yu, Z. (2019) LncRNA NEF Is Downregulated in Triple Negative Breast Cancer and Correlated with Poor Prognosis. Acta Biochimica et Biophysica Sinica, 51, 386-392. https://doi.org/10.1093/abbs/gmz021
|
[11]
|
Zhang, W., Chen, C.-J. and Guo, G.-L. (2018) MiR-155 Promotes the Proliferation and Migration of Breast Cancer Cells via Targeting SOCS1 and MMP16. European Review for Medical and Pharmacological Sciences, 22, 7323-7332.
|
[12]
|
周琦, 吴小华, 刘继红, 等. 宫颈癌诊断与治疗指南(第四版) [J]. 中国实用妇科与产科杂志, 2018, 34(6): 613-622.
|
[13]
|
Lei, C., Wang, Y., Huang, Y., Yu, H., Huang, Y., Wu, L. and Huang, L. (2012) Up-Regulated miR155 Reverses the Epithelial-Mesenchymal Transition Induced by EGF and Increases Chemo-Sensitivity to Cisplatin in Human Caski Cervical Cancer Cells. PLOS ONE, 7, e52310. https://doi.org/10.1371/journal.pone.0052310
|
[14]
|
Qureshi, R., Arora, H. and Rizvi, M.A. (2015) EMT in Cervical Cancer: Its Role in Tumour Progression and Response to Therapy. Cancer Letters, 356, 321-331. https://doi.org/10.1016/j.canlet.2014.09.021
|
[15]
|
Lao, G., Liu, P., Wu, Q., Zhang, W., Liu, Y., Yang, L. and Ma, C. (2014) Mir-155 Promotes Cervical Cancer Cell Proliferation through Suppression of Its Target Gene LKB1. Tumor Bi-ology, 35, 11933-11938.
https://doi.org/10.1007/s13277-014-2479-7
|
[16]
|
Fang, H., Shuang, D., Yi, Z., Sheng, H. and Liu, Y. (2016) Up-Regulated microRNA-155 Expression Is Associated with Poor Prognosis in Cervical Cancer Patients. Biomedicine & Pharmacotherapy, 83, 64-69.
https://doi.org/10.1016/j.biopha.2016.06.006
|
[17]
|
Chen, Y.-Z., Wang, J.-W., Meng, F.-C., Yang, P., Zhang, X.-G. and Wu, H.-Z. (2019) LncRNATCF7 up-Regulates DNMT1 Mediated by HPV-18 E6 and Regulates Biological Behav-ior of Cervical Cancer Cells by Inhibiting miR-155. European Review for Medical and Pharmacological Sciences, 23, 8779-8787.
|
[18]
|
Jia, J., Li, X., Guo, S. and Xie, X. (2020) MicroRNA-155 Suppresses the Translation of p38 and Im-pairs the Functioning of Dendritic Cells in Endometrial Cancer Mice. Cancer Management and Research, 12, 2993-3002.
https://doi.org/10.2147/CMAR.S240926
|
[19]
|
Hermyt, E., Zmarzły, N., Grabarek, B., Kruszniewska-Rajs, C., Gola, J., Jęda-Golonka, A., Szczepanek, K., Mazurek, U. and Witek, A. (2019) Interplay between miRNAs and Genes Associ-ated with Cell Proliferation in Endometrial Cancer. International Journal of Molecular Sciences, 20, Article No. 6011. https://doi.org/10.3390/ijms20236011
|
[20]
|
刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
|
[21]
|
Shao, C., Yang, F., Qin, Z., Jing, X., Shu, Y. and Shen, H. (2019) The Value of miR-155 as a Biomarker for the Diagnosis and Prognosis of Lung Cancer: A Systematic Review with Me-ta-Analysis. BMC Cancer, 19, Article No. 1103.
https://doi.org/10.1186/s12885-019-6297-6
|
[22]
|
Zhu, H.-Z., Hou, J., Guo, Y., Liu, X., Jiang, F.-L., Chen, G.-P., Pang, X.-F., Sun, J.-G. and Chen, Z.-T. (2018) Identification and Imaging of miR-155 in the Early Screening of Lung Cancer by Targeted Delivery of Octreotide-Conjugated Chitosan-Molecular Beacon Nanoparticles. Drug Delivery, 25, 1974-1983.
https://doi.org/10.1080/10717544.2018.1516003
|
[23]
|
Zang, Y.-S., Zhong, Y.-F., Fang, Z., Li, B. and An, J. (2012) MiR-155 Inhibits the Sensitivity of Lung Cancer Cells to Cisplatin via Negative Regulation of Apaf-1 Expression. Can-cer Gene Therapy, 19, 773-778.
https://doi.org/10.1038/cgt.2012.60
|
[24]
|
吕炎, 王艳华, 苏利佳, 苏华华. miRNA-122在肿瘤发生发展中的研究进展[J]. 癌症进展, 2021, 19(18): 1847-1851.
|
[25]
|
Li, C.-L., Nie, H., Wang, M., Su, L.-P., Li, J.-F., Yu, Y.-Y., Yan, M., Qu, Q.-L., Zhu, Z.-G. and Liu, B.-Y. (2012) MicroRNA-155 Is Downregulated in Gastric Cancer Cells and Involved in Cell Metastasis. Oncology Reports, 27, 1960-1966.
|
[26]
|
Ma, Z., Ma, Y., Xia, Q., Li, Y., Li, R., Chang, W., Chen, J., Leng, Z. and Tao, K. (2016) MicroRNA-155 Expression Inversely Correlates with Pathologic Stage of Gastric Cancer and It Inhibits Gastric Cancer Cell Growth by Targeting Cyclin D1. Journal of Cancer Research and Clinical Oncology, 142, 1201-1212.
https://doi.org/10.1007/s00432-016-2139-y
|
[27]
|
张南翔. miRNA-155在胃癌中的表达及意义[D]: [硕士学位论文]. 长沙: 中南大学, 2014.
|
[28]
|
曹兵, 季涛, 周斌, 等. miRNA-155在胃癌组织中的表达及意义[J]. 实用临床医药杂志, 2013, 17(21): 43-45.
|
[29]
|
Li, Y., Tian, Z., Tan, Y., Lian, G., Chen, S., Chen, S., Li, J., Li, X., Huang, K. and Chen, Y. (2020) Bmi-1-Induced miR-27a and miR-155 Promote Tumor Metastasis and Chemoresistance by Target-ing RKIP in Gastric Cancer. Molecular Cancer, 19, Article No. 109. https://doi.org/10.1186/s12943-020-01229-y
|
[30]
|
Qu, Y., Zhang, H., Sun, W., Han, Y., Li, S., Qu, Y., Ying, G. and Ba, Y. (2018) MicroRNA-155 Promotes Gastric Cancer Growth and Invasion by Negatively Regulating Transform-ing Growth Factor-β Receptor 2. Cancer Science, 109, 618-628. https://doi.org/10.1111/cas.13472
|
[31]
|
Yin, L., Liu, T., Li, C., Yan, G., Li, C., Zhang, J. and Wang, L. (2020) The MRTF-A/miR-155/SOX1 Pathway Mediates Gastric Cancer Migration and Invasion. Cancer Cell International, 20, Article No. 303.
https://doi.org/10.1186/s12935-020-01395-5
|
[32]
|
Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M.T., Gad, M., Al-Husseini, M. and Saad, A. (2021) Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Current Drug Targets, 22, 998-1009. https://doi.org/10.2174/1389450121999201117115717
|
[33]
|
Nassar, F.J., Msheik, Z.S., Itani, M.M., Helou, R.E., Hadla, R., Kreidieh, F., Bejjany, R., Mukherji, D., Shamseddine, A., Nasr, R.R. and Temraz, S.N. (2021) Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis. Diagnostics, 11, Article No. 341. https://doi.org/10.3390/diagnostics11020341
|
[34]
|
Zhang, X.-F., Tu, R., Li, K., Ye, P. and Cui, X. (2017) Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer. Journal of Cellular Biochemistry, 118, 3391-3400. https://doi.org/10.1002/jcb.25995
|
[35]
|
Liu, N., Jiang, F., Han, X.-Y., Li, M., Chen, W.-J., Liu, Q.-C., Liao, C.-X. and Lv, Y.-F. (2018) MiRNA-155 Promotes the Invasion of Colorectal Cancer SW-480 Cells through Regulating the Wnt/β-Catenin. European Review for Medical and Pharmacological Sciences, 22, 101-109.
|
[36]
|
吕桂帅, 陈磊, 王红阳. 我国肝癌研究的现状与前景[J]. 生命科学, 2015, 27(3): 237-248.
|
[37]
|
Wang, Q., Wang, G.-T. and Lu, W.-H. (2021) MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1. Technolo-gy in Cancer Research & Treatment, 20, Article ID: 1533033820957021.
https://doi.org/10.1177/1533033820957021
|
[38]
|
Niu, L.-J., Huang, T., Wang, L., Sun, X.-F. and Zhang, Y.-M. (2022) HBX Suppresses PTEN to Promote the Malignant Progression of Hepatocellular Carcinoma through mi-R155 Activation. Annals of Hepatology, 27, Article ID: 100688. https://doi.org/10.1016/j.aohep.2022.100688
|
[39]
|
Zheng, Z., Sun, R., Zhao, H.-J., Fu, D., Zhong, H.-J., Weng, X.-Q., Qu, B., Zhao, Y., Wang, L. and Zhao, W.-L. (2019) MiR155 Sensitized B-Lymphoma Cells to Anti-PD-L1 Antibody via PD-1/PD-L1-Mediated Lymphoma Cell Interaction with CD8+T Cells. Molecular Cancer, 18, Article No. 54. https://doi.org/10.1186/s12943-019-0977-3
|
[40]
|
Ahmadvand, M., Eskandari, M., Pashaiefar, H., Yaghmaie, M., Manoochehrabadi, S., Khakpour, G., Sheikhsaran, F. and Montazer Zohour, M. (2018) Over Expression of Circulating miR-155 Predicts Prognosis in Diffuse Large B-Cell Lymphoma. Leukemia Research, 70, 45-48. https://doi.org/10.1016/j.leukres.2018.05.006
|
[41]
|
Yu, Y., Kou, D., Liu, B., Huang, Y., Li, S., Qi, Y., Guo, Y., Huang, T., Qi, X. and Jia, L. (2020) LncRNA MEG3 Contributes to Drug Resistance in Acute Myeloid Leukemia by Positively Regulating ALG9 through Sponging miR-155. International Journal of Laboratory Hematology, 42, 464-472. https://doi.org/10.1111/ijlh.13225
|
[42]
|
Wang, H. and Men, C.-P. (2015) Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis. Laboratory Medicine, 46, 118-122. https://doi.org/10.1309/LMWR9CEA2K2XVSOX
|
[43]
|
Yang, L., Li, C., Liang, F., Fan, Y. and Zhang, S. (2017) MiRNA-155 Promotes Proliferation by Targeting Caudal-Type Homeobox 1 (CDX1) in Glioma Cells. Biomedicine & Pharmacotherapy, 95, 1759-1764.
https://doi.org/10.1016/j.biopha.2017.08.088
|
[44]
|
Chen, W., He, L.-N., Liang, Y., Zeng, X., Wu, C.-P., Su, M.-Q., Cheng, Y. and Liu, J.-H. (2020) TERF1 Downregulation Promotes the Migration and Invasion of the PC3 Prostate Can-cer Cell Line as a Target of miR-155. Molecular Medicine Reports, 22, 5209-5218. https://doi.org/10.3892/mmr.2020.11623
|